Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
rimactan hart hylki 300 mg
sandoz gmbh* - rifampicinum inn - hart hylki - 300 mg
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
rimactan hart hylki 150 mg
sandoz gmbh* - rifampicinum inn - hart hylki - 150 mg
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 0,5 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 0,5 mg
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 1 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 1 mg
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 2 mg
sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 3 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
vagidonna leggangatafla 10 míkróg
sandoz a/s* - estradiol - leggangatafla - 10 míkróg
Unia Europejska -
islandzki -
EMA (European Medicines Agency)
corbilta (previously levodopa/carbidopa/entacapone sandoz)
orion corporation - algengari ddc hemli, ef - parkinsonsveiki - anti-parkinsonslyf - corbilta er ætlað til meðferðar hjá fullorðnum sjúklingum með parkinsonsveiki og skammtahreyfingar í upphafi skammts sem ekki eru stöðugir á meðferð með levodopa / dopa decarboxylasa (ddc).
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
fortum stungulyfs-/innrennslisstofn, lausn 2 g
sandoz a/s - ceftazidimum inn - stungulyfs-/innrennslisstofn, lausn - 2 g
Islandia -
islandzki -
LYFJASTOFNUN (Icelandic Medicines Agency)
fortum stungulyfsstofn, lausn 1 g
sandoz a/s - ceftazidimum inn - stungulyfsstofn, lausn - 1 g